Opus Genetics (IRD) Accounts Payables (2010 - 2026)

Opus Genetics (IRD) has 17 years of Accounts Payables data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 81.98% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 81.98% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 4.61% from the prior year.
• Accounts Payables for Q1 2026 stood at $4.4 million, up from $3.3 million in the prior quarter.
• Over the last five years, Accounts Payables for IRD reached as high as $4.4 million in Q1 2026 and fell as low as $634000.0 in Q2 2024.
• Historically, Accounts Payables has averaged $2.1 million across 5 years, with a median of $2.1 million in 2024.
• Across the five-year window, Accounts Payables sank 72.71% in 2024 and surged 183.77% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $1.1 million in 2022, then jumped by 101.4% to $2.2 million in 2023, then soared by 46.21% to $3.1 million in 2024, then climbed by 4.61% to $3.3 million in 2025, then soared by 34.28% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $4.4 million in Q1 2026, $3.3 million in Q4 2025, and $2.4 million in Q3 2025.